The most viewed presentations, reports, and documents from Relmada Therapeutics, Inc..
Relmada Therapeutics CNS Treatment 2024 Investor Presentation
investor_presentation
41 Pages
Relmada Therapeutics 2022 Earnings Call REL-1017 Results
earnings
13 Pages